News

Award-winning theatre star Jeanne Ní Áinle has been enjoying the move from stage to screen, with upcoming roles in filmmaker David Lowery’s melodrama Mother Mary alongside Michaela Coel and ...
The board of Ornapaper Berhad (KLSE:ORNA) has announced that it will pay a dividend on the 20th of May, with investors receiving MYR0.02 per share. This means that the annual payment will be 2.2% ...
WATERTOWN, Mass., March 31, 2025 /PRNewswire/ -- Orna Therapeutics, a biotechnology company dedicated to engineering immune cells in vivo to treat oncology and autoimmune diseases, today announced ...
Still, it is what it is and benefits from the presence of Áine Ní Bhreisleáin, a likeable host on an engaging, emotional journey. As with many people, Ní Bhreisleáin has experienced burnout ...
The board of TG4 has announced that Deirdre Ní Choistín has been appointed director general of TG4 with the statutory consent of the Government following a competitive public recruitment process.
Last week was particularly difficult in Israel due to the appalling condition of the hostages who were returned as mere shadows of themselves, as well as the bombardment of manipulative ...
One surprise nominee is sports broadcaster Evanne Ní Chuilinn, who has resigned from RTÉ and joined Fine Gael. Five of the six Fianna Fáil nominees named by Mr Martin are women. They are former ...
RTÉ sports journalist Evanne Ní Chuilinn is to become a Fine Gael senator, as Taoiseach Micheál Martin unveiled his 11 Seanad nominees. In a surprise announcement on Friday, Tánaiste Simon ...
It took a superstar couples therapist to help me see beyond my anger. The author Daniel Oppenheimer and his wife, Jess, rewatching a recording of their Zoom sessions with the couples therapist and ...
Vertex Pharmaceuticals will work together with Orna Therapeutics over the next three years to develop technology that would help enable “in vivo” gene therapies for sickle cell disease and ...
Vertex Pharmaceuticals is hoping to build upon its existing rare blood disease treatment portfolio, teaming up with Orna Therapeutics’ ReNAgade in efforts to develop next-gen gene therapies for ...
-- Orna to receive an upfront payment and is eligible to receive potential pre-clinical, clinical, and commercialization milestone payments and royalties -- WATERTOWN, Mass., Jan. 7, 2025 ...